Angela Rogers

Professor-Univ Med Line, Medicine - Pulmonary, Allergy & Critical Care Medicine

Bio

Dr. Rogers is an expert in Pulmonary and Critical Care Medicine and works as a physician in the Intensive Care Unit. She has a translational research focus on sepsis and Acute Respiratory Distress Syndrome (ARDS). She uses genomic data from patient samples to both understand severity of illness and prognosis, and to help design clinical trials that target the patients who could most benefit from emerging therapies. She is very active in mentoring residents and fellows in ICU research and clinical medicine.

Clinical Focus

Critical Care
Critical Care Medicine

Academic Appointments

Professor-Univ Med Line, Medicine - Pulmonary, Allergy & Critical Care Medicine
Member, Bio-X
Member, Cardiovascular Institute

Administrative Appointments

Associate Director, Stanford Pulmonary and Critical Care Fellowship (2015 - Present)
Associate Program Director, Stanford Internal Medicine Residency (2015 - Present)

Honors & Awards

Physician of the Year, Stanford Health Care (2021)

Boards, Advisory Committees, Professional Organizations

Committee Chair-Elect, Allergy, Immunology, and Inflammation Assembly, American Thoracic Society, (2022 - Present)

Professional Education

Board Certification: American Board of Internal Medicine, Pulmonary Disease (2006)
Fellowship: Massachusetts General Hosp Harvard Med School (2009) MA
Board Certification: American Board of Internal Medicine, Critical Care Medicine (2007)
Residency: Brigham and Women's Hospital Harvard Medical School (2004) MA
Internship: Brigham and Women's Hospital Harvard Medical School (2002) MA
Medical Education: Harvard Medical School (2001) MA

Contact

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Pulmonary Clinic 300 Pasteur Dr A165 Stanford CA 94305 Tel: (650) 725-7061 Fax: (650) 498-6288

Additional Clinical Info

Stanford Health Care

Current Research and Scholarly Interests

We use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.

Clinical Trials

ARrest RESpiraTory Failure From PNEUMONIA Not Recruiting
More
This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

Stanford is currently not accepting patients for this trial. For more information, please contact Vojnik, Rosemary, 650-723-6381.

Lead Sponsor
- Stanford University
Stanford Investigators
- Angela Rogers
- Joe Levitt, MD
View full details
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk" Recruiting
More
Approximately 150 patients with acute kidney injury (AKI) associated with acute hypoxemic respiratory failure (AHRF) will be randomized at up to 40 sites. Patients will be randomly assigned to either Auxora or matching placebo. Study drug infusions will occur every 24 hours for five consecutive days for a total of five infusions.
Lead Sponsor
Stanford Investigators
- Vikram Fielding-Singh, MD, JD
- Angela Rogers
View full details
ACTIV-3: Therapeutics for Inpatients With COVID-19 Not Recruiting
More
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
View full details
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis Not Recruiting
More
Multicenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension.

Stanford is currently not accepting patients for this trial. For more information, please contact Vojnik, Rosemary, .
Lead Sponsor
Stanford Investigators
- Angela Rogers
- Joe Eric Levitt
View full details
The APS Phenotyping Study Recruiting
More
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS, sepsis, and/or pneumonia.
Lead Sponsor
Stanford Investigators
- Angela Rogers
View full details
Vaccination for Recovered Inpatients With COVID-19 (VATICO) Not Recruiting
More
In this Phase 4, open-label trial, participants of the ACTIV-3/TICO clinical trial at selected sites who received certain pre-specified blinded investigational agents or placebo as part of that trial, and who have since achieved sustained recovery, and who are still \[TICO assignment\] blinded and who are still within 28 to 90 days after initial TICO randomization, will be randomized in this 2x2 factorial design to one of four groups: (i) immediate versus 12 week deferral of first dose administration and also (ii) one dose only, versus two doses to be given 4 weeks apart of the Moderna mRNA-1273 or the Pfizer BNT162b2 vaccine (mRNA vaccines). Choice of Moderna or Pfizer vaccine is determined based on availability at the site. The choice is individual, although participants vaccinated twice should receive the same type of vaccine for both injections. The primary objectives of this 2x2 factorial design are (i) to estimate the difference in neutralizing antibody (NAb) response to the mRNA vaccine from baseline to Week 48 among participants vaccinated early versus deferred, and (ii) to estimate the difference in NAb response to this vaccine among participants vaccinated once versus twice. The primary analyses will be carried out in participants randomized to placebo in TICO. Analyses will also be carried out for those who receive the investigational agent(s) studied in TICO. A key secondary objective is to ascertain the effect, if any, of SARS-CoV-2 monoclonal antibodies, and other interventions that have been studied in hospitalized COVID-19 subjects, on natural and vaccine-induced immunity. Participants will remain blinded to the interventions received in the ACTIV-3/TICO study, however allocation to the timing of vaccination and to one or two vaccinations in this (VATICO) study is not blinded.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .
Lead Sponsor
Stanford Investigators
- Angela Rogers
View full details

2025-26 Courses

Independent Studies
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)

Stanford Advisees

Postdoctoral Faculty Sponsor
Caitlin Contag, Joseph Rathkey

All Publications

Profiles With Related Publications

close
Neera Ahuja

Professor of Medicine (Hospital Medicine)
Clinical Focus
Clinical operations, Artificial Intelligence/LLM, Health Equity, Clinical Trials, Building innovative care models, Promoting physician resilience as a tool for wellness, Development of a Perioperative Medical Service for surgical co-management, Quality Improvement, Inpatient Medical Education of Housestaff, Internal Medicine
Research Interests
Clinical inpatient trials, Quality improvement, Assessing interventions with operations on throughput. SDOH/Health equity
Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system

127 Total Publications
close
Harmeet Bedi

Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Clinical Focus
Interventional Pulmonology, Thoracic Oncology, Rigid & Flexible Bronchoscopy, Robotic Bronchoscopy, Airway Obstruction (Tracheal and Bronchial), Lung Nodules, Lung Cancer, Pleural Disease, Lung Transplant Complications, Critical Care Medicine

24 Total Publications
close
Alice Bertaina MD, PhD

Lorry I. Lokey Professor
Clinical Focus
Pediatric Stem Cell Transplantation, Graft engineering, Pediatric Hematology-Oncology

232 Total Publications
close
Linda N. Geng, MD, PhD

Clinical Associate Professor, Medicine - Primary Care and Population Health
Clinical Focus
Long COVID and Post-Infectious Syndromes, Complex and Puzzling Conditions, Undiagnosed Diseases and Medical Mysteries, Rare Disorders, Diagnostic Medicine, Internal Medicine

64 Total Publications
close
Brianna Johnson

Ph.D. Student in Biology, admitted Autumn 2023 Grad Writing Tutor, Hume Center

10 Total Publications
close
Joseph Levitt, MD, MS

Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Clinical Focus
Pulmonary Critical Care, Critical Care Medicine
Research Interests
My research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).

75 Total Publications
close
Kuan Ting Liu

Postdoctoral Scholar, Microbiology and Immunology

3 Total Publications
close
Holden Maecker

Professor (Research) of Microbiology and Immunology
Research Interests
I'm interested in immune monitoring of T cell responses to chronic pathogens and cancer, and the correlation of T cell response signatures with disease protection.

235 Total Publications
close
Eric Meffre

Professor of Medicine (Immunology and Rheumatology)

55 Total Publications
close
David Miklos

James and Katherine Lau Professor
Clinical Focus
Cancer > Blood and Marrow Transplant, Cancer > Hematology, Chimeric Antigen Receptor Therapy (CAR-T), Blood and Marrow Transplantation, Graft vs Host Disease, Lymphoma , Leukemia, Multiple Myeloma, Hematology
Research Interests
Dr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.

136 Total Publications
close
Carlos Milla

Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Clinical Focus
Cystic Fibrosis, Primary Ciliary Dyskinesia, Bronchopulmonary Dysplasia, Pulmonary Hypertension, Rare Lung Diseases, Pediatric Lung and Heart-Lung Transplantation, Pediatric Pulmonology
Research Interests
At Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.

249 Total Publications
close
Andrew Reese Moore

Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Clinical Focus
Critical Care Medicine

30 Total Publications